目的:本研究旨在探讨影像学信息,实验室数据,十二指肠乳头状恶性肿瘤的临床特征,旨在有助于这些疾病的早期诊断。
方法:临床特征,实验室数据,回顾性分析17例十二指肠乳头腺瘤(腺瘤组)和58例十二指肠乳头癌(癌)的计算机断层扫描(CT)表现。测量数据采用t检验进行分析,以平均值±标准差表示。计数数据采用χ2检验进行分析,以n(%)表示。还进行了Pearson相关分析,并绘制了散点图。
结果:直径有显著差异,形状,margin,和十二指肠主要乳头的目标标志,胰管直径,胆总管直径,增强均匀性,发烧,直接胆红素,总胆红素,癌胚抗原,糖抗原19-9,腺瘤组和癌症组之间的黄疸(P<0.01)。十二指肠乳头的增强幅度与病变大小相关,增强扫描的静脉期CT值与十二指肠乳头直径相关(P<0.05)。此外,癌症组中有12例患者患有腺瘤的恶变。
结论:首先,CT在十二指肠乳头疾病的诊断中具有较高的价值。其次,十二指肠乳头的增强幅度与病变大小相关。第三,十二指肠乳头腺瘤患者有进展为腺癌的风险,因此需要密切跟进。
OBJECTIVE: This study was conducted to investigate the imaging information, laboratory data, and clinical characteristics of duodenal papillary malignancies, aiming to contribute to the early diagnosis of these diseases.
METHODS: The clinical characteristics, laboratory data, and computed tomography (CT) findings of 17 patients with adenoma of the major duodenal papilla (the adenoma group) and 58 patients with cancer of the major duodenal papilla (the cancer group) were retrospectively analyzed. The measurement data were analyzed using t test and expressed as mean ± standard deviation. The counting data were analyzed using the χ2 test and expressed in n (%). Pearson correlation analysis was also conducted, and a scatter plot was drawn.
RESULTS: There were significant differences in the diameter, shape, margin, and target sign of the major duodenal papilla, pancreatic duct diameter, common bile duct diameter, enhancement uniformity, fever, direct bilirubin, total bilirubin, carcinoembryonic antigen, carbohydrate antigen 19-9, and jaundice between the adenoma group and the cancer group (P < .01). The enhancement magnitude of the duodenal papilla was correlated with the lesion size, and the venous phase CT value of the enhanced scan was correlated with the duodenal papilla diameter (P < .05). Additionally, 12 patients in the cancer group suffered from malignant transformation of adenomas.
CONCLUSIONS: Firstly, CT is of high value in the diagnosis of duodenal papilla diseases. Secondly, the enhancement magnitude of the duodenal papilla is correlated with the lesion size. Thirdly, patients with duodenal papilla adenomas have a risk of progression into adenocarcinoma, thereby requiring close follow-up.